SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001193125-21-120471
Filing Date
2021-04-19
Accepted
2021-04-19 09:11:00
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC 13G d119656dsc13g.htm SC 13G 31303
  Complete submission text file 0001193125-21-120471.txt   32571
Mailing Address 500 TECHNOLOGY SQUARE SUITE 700 CAMBRIDGE MA 02139
Business Address 500 TECHNOLOGY SQUARE SUITE 700 CAMBRIDGE MA 02139 617-586-3100
Foghorn Therapeutics Inc. (Subject) CIK: 0001822462 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-91795 | Film No.: 21833383
SIC: 2834 Pharmaceutical Preparations

Mailing Address 100 BINNEY STREET SUITE 610 CAMBRIDGE MA 02142
Business Address
KADOCH CIGALL (Filed by) CIK: 0001828726 (see all company filings)

Type: SC 13G